Real-time availability status for Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications
Last checked: July 4, 2026
Ozempic, Wegovy, Rybelsus
Mounjaro, Zepbound
Saxenda, Victoza
Brand names: Ozempic, Wegovy, Rybelsus
3 shortage record(s) found in FDA database:
Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)
Novo Nordisk, Inc.
Updated: 06/04/2026
Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)
Novo Nordisk, Inc.
Updated: 06/04/2026
Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)
Novo Nordisk, Inc.
Updated: 06/04/2026
Brand names: Mounjaro, Zepbound
No current shortages reported for tirzepatide products.
Brand names: Saxenda, Victoza
10 shortage record(s) found in FDA database:
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)
Novo Nordisk, Inc.
Updated: 06/08/2026
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)
Meitheal Pharmaceuticals, Inc.
Updated: 06/01/2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)
Hikma Pharmaceuticals USA, Inc.
Updated: 06/25/2026
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)
Teva Pharmaceuticals USA, Inc.
Updated: 05/14/2026
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
Meitheal Pharmaceuticals, Inc.
Updated: 06/01/2026
Subscribe to receive updates when GLP-1 medication availability changes
Data sourced from the FDA Drug Shortage Database. Updated weekly via the openFDA API.